Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The dengue vaccine Dengvaxia has been approved by the U.S. Food and Drug Administration for use in the U.S. territories of American Samoa

FDA Approves Dengue Vaccine for Endemic Regions

0
Vaccine indicated for individuals aged 9 to 16 who have previously had laboratory-confirmed dengue disease
A type of breast implant linked to cancer can still be sold in the United States

FDA: Breast Implants Linked to Cancer Can Still Be Sold in U.S.

0
Agency considering new patient warnings and checklists for the implants
Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus in children ages 12 to 17 years

FDA Approves Mavyret for Children, Adolescents With Hep C

0
Drug approved for treatment of all six genotypes of hepatitis C virus in children ages 12 to 17
The U.S. Food and Drug Administration is requiring a new boxed warning on sleep medications such as Ambien

FDA Puts Tough Warning Label on Ambien, Lunesta, Other Sleep Aids

0
Move spurred by 66 cases of 'complex sleep behaviors' after taking the insomnia medications
The U.S. Food and Drug Administration announced the approval of a new device on Friday that aims to increase the number of lungs available for transplant.

FDA Approves Device That Allows for Reassessment of Lung Transplant Suitability

0
With Xvivo Perfusion System, surgeons can reassess lungs originally considered unsuitable for transplant
The first treatment has been approved for children with systemic lupus erythematosus

FDA Approves First Treatment for Pediatric Lupus

0
Approval based on study showing children who received Benlysta plus standard therapy had lower risk for flare
The U.S. Food and Drug Administration this week announced three new efforts to protect patients from malfunctions

FDA Announces New Steps to Reduce Risks Tied to Surgical Staplers

0
Agency proposing higher classification of surgical staplers that will require premarket notification clearance
The combination of pembrolizumab and axitinib has been approved as a first-line treatment in advanced renal cell carcinoma

FDA Approves Pembrolizumab Plus Axitinib for Advanced RCC

0
Drug combination approved for advanced renal cell carcinoma based on findings from KEYNOTE-426
Marketing has been approved for the first medical device to treat attention-deficit/hyperactivity disorder

FDA Approves Marketing of First Device to Treat ADHD

0
Monarch eTNS System approved for children 7 to 12 years old not taking prescription ADHD medication
The first generic naloxone nasal spray to treat opioid overdose has received approval from the U.S. Food and Drug Administration.

FDA Approves First Generic Nasal Spray Against Opioid Overdose

0
Product is also first generic naloxone nasal spray approved for use by people without medical training